SIBIONICS, the world’s third-largest Continuous Glucose Monitoring (CGM) System brand, will be showcasing its latest CGM solutions for diabetes management at the 17th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD) in Florence, Italy from 6-9 March 2024.
With over 1,800 hospital collaborations, SIBIONICS has successfully integrated CGM for inpatient treatment, benefiting over 850,000 individuals globally in managing diabetes. In addition, SIBIONICS is constructing an automated production line with an annual capacity of 18 million CGM sets, which is expected to be completed in 2024.
As part of its commitment to customer-centric innovation, SIBIONICS has entered the European market following its CE MDR certification in October 2023. The company has received positive user feedback and has expanded global partnerships due to its strong product capabilities. SIBIONICS is focusing on engaging with users for a co-developed CGM solution for Type 1 and Type 2 diabetes, prediabetes, and metabolic disorders, emphasizing the importance of blood glucose management and delivering high-quality, comprehensive diabetes solutions for overall health improvement.
During the ATTD conference, SIBIONICS will be hosting the SIBIONICS Influencer Talk: Realizing the Unimagined event on March 9, 2024. This event will feature healthcare professionals, dietitians, and opinion leaders in the field of diabetes management who will gather to discuss the extensive potential of CGM technology and its pivotal role in crafting future diabetes management solutions. Attendees can look forward to thought-provoking presentations, interactive Q&A sessions, and discussions on the company’s upcoming product launches, including the new versions of the GS1 CGM (GS2), the reusable transmitter (GS ECO), and the combined glucose and ketone monitor. The event will take place at the Hilton Garden Inn Florence Novoli in Florence, Italy.
SIBIONICS is grateful to all the speakers and brand partners who will be attending this event and looks forward to continuing the conversation and pushing the boundaries of CGM innovation in its future events.
For further information about the event and SIBIONICS’ products, please contact the SIBIONICS PR Team.
SIBIONICS is a pioneer in the field of diabetes management and has set high standards for CGM technology. The company’s dedication to user-focused innovation and comprehensive solutions demonstrates its commitment to improving overall health and well-being for individuals managing diabetes.
Source link
